Plain-English translation of NCT06738966 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a new experimental drug called to see if it can help treat advanced cancers that depend on hormones to grow — including breast, ovarian, and endometrial cancer in postmenopausal women. The study will check whether the medication is safe to take and whether it slows or stops cancer growth. Because this is an early-stage trial, the main focus is on understanding how your body tolerates the medication and finding the right dose.
Many postmenopausal women with hormone-sensitive cancers stop responding to standard hormone therapies, leaving them with few options. This medication is being tested as a potential new treatment for women in that situation.
You likely qualify if…
You likely don't qualify if…
You would receive the medication at different dose levels (the study will test doses ranging from 50 mg to 500 mg) as part of a small group of about 9 participants total. You would likely visit the clinic regularly so doctors can check your blood work, monitor for side effects, and scan your tumors to see if the treatment is working. The exact number of visits and duration will depend on how you respond to the medication and any side effects you experience.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China